916986
NanoFabTx™ device accessory
top interface
Sinónimos:
Microfluidic kit, NanoFabTx™, Nanoformulation
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
UNSPSC Code:
41121800
NACRES:
NA.23
Productos recomendados
![5-[Di(1-adamantyl)phosphino]-1′,3′,5′-triphenyl-1′H-[1,4′]bipyrazole 97%](/deepweb/assets/sigmaaldrich/product/structures/334/020/2da77724-fc86-4d88-bc93-0b43ae777daa/640/2da77724-fc86-4d88-bc93-0b43ae777daa.png)
![5-(Di-tert-butylphosphino)-1′, 3′, 5′-triphenyl-1′H-[1,4′]bipyrazole 97%](/deepweb/assets/sigmaaldrich/product/structures/137/599/8b2f4b58-3384-40aa-9295-0887f7985525/640/8b2f4b58-3384-40aa-9295-0887f7985525.png)
description
Microfludic hardware kit component
Kit components : Top Inerface x 1
Quality Level
application(s)
advanced drug delivery
¿Está buscando productos similares? Visita Guía de comparación de productos
Categorías relacionadas
General description
NanoFabTx™ device accessory, top interface is a component of our NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 µm particles (911860). The kit additionally includes a protocol, microfluidic chip, connectors, tubing, and additional accessories for microfluidic-based synthesis.
Application
NanoFabTx™ device accessory, top interface facilitates fluidic connections from two linear connectors to the microfluidic chip. NanoFabTx™ device accessory, top interface, 10m can be used as a replacement for the component in our NanoFabTx™ microfluidic device kits (911860).
Legal Information
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
Related product
Referencia del producto
Descripción
Precios
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico